News
-
-
PRESS RELEASE
From Silicon Valley to Mainstream Medicine: How elegant hoopoe 'Longevity Scores' Are Revolutionising Preventive Healthcare
elegant hoopoe revolutionizes preventive healthcare by assigning personalized 'Longevity Scores' based on 56 biomarkers, bringing Silicon Valley biohacking to mainstream medicine -
PRESS RELEASE
QUANTRO Therapeutics extends collaboration with Boehringer Ingelheim to address high unmet needs in cancer patients
QUANTRO Therapeutics extends collaboration with Boehringer Ingelheim to develop innovative cancer treatments, targeting transcription factors. Collaboration aims to address high unmet needs in cancer patients -
-
PRESS RELEASE
The new European Circular Textile Coalition calls for a circular textile economy: "a world without waste is possible"
Reju and 11 companies launch European Circular Textile Coalition manifesto for a circular textile economy, urging EU action to transform textile waste into green jobs and innovation -
PRESS RELEASE
Star Copper Drill Program Mobilizes Additional Rig at Copper Creek to Test High Value Historic Target in BC
Star Copper Corp. finalizes preparations for maiden drill program at Copper Creek target near flagship project in British Columbia. Extensive work completed for drill-ready stage. Historic holes and high-grade exposures to be tested -
PRESS RELEASE
Apex Acquires Additional REE Rights and Consolidates Priority Target Area at The Elk Creek Rift Project, Nebraska
Apex Critical Metals Corp. acquires additional rare earth exploration rights in Elk Creek Rift Project, Nebraska, USA, enhancing potential for critical minerals. CEO plans inaugural drilling program by year-end -
PRESS RELEASE
Closing of acquisition: SBO strengthens Precision Technology division with 3T Additive Manufacturing Ltd.
SBO AG strengthens Precision Technology division by acquiring 3T Additive Manufacturing Ltd., a British industrial 3D metal printing solutions provider. The acquisition enhances technology leadership and sustainability -
PRESS RELEASE
AB Science will hold a virtual conference on Thursday, October 16, 2025 from 2pm to 3pm CET to provide an update on the Phase 1 study with AB8939
AB Science releases positive initial data on combination treatment of AB8939 with Venetoclax for refractory or relapsed Acute Myeloid Leukemia (AML), showing promising results in patients with unfavorable genetic profiles. Virtual conference scheduled with renowned experts in AML -
PRESS RELEASE
AB Science tiendra une conférence virtuelle le jeudi 16 octobre 2025, de 14 h à 15 h CET, afin de faire le point sur l'étude de phase 1 avec AB8939
AB Science publie les premières données de la combinaison de AB8939 avec Vénétoclax dans le traitement de la LMA, avec des résultats très encourageants. Une conférence virtuelle est prévue le 16 octobre 2025
